AtulRMahableshwarkarMD

PubMed

• 4 citations
  Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-te...
  Atul R. Mahableshwarkar, John Affinito, Elin Heldbo Reines, Judith Xu, George G. Nomikos, Paula L. Jacobsen> ;CNS Spectrums. 2020 Jun 1
• 29 citations
  A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia.
  Thomas A. Macek, Maggie McCue, Xinxin Dong, Elizabeth Hanson, Paul Goldsmith, John Affinito, Atul R. Mahableshwarkar> ;Schizophrenia Research. 2019 Feb 1
• 8 citations
  What is the overlap between subjective and objective cognitive impairments in MDD
  Maurizio Fava, Atul R. Mahableshwarkar, William Jacobson, Wei Zhong, Richard S.E. Keefe, Christina Kurre Olsen, Judith Jaeger> ;Annals of Clinical Psychiatry. 2018 Aug 1
• 30 citations
  Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressiv...
  Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai, Tadayuki Kitagawa, Atul R. Mahableshwarkar> ;Psychiatry and Clinical Neurosciences. 2018 Feb 1
• 16 citations
  Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial.
  Atul R. Mahableshwarkar, Joseph R. Calabrese, Thomas A. Macek, Kumar Budur, Adedeji Adefuye, Xinxin Dong, Elizabeth Hanson, Gary S. Sachs> ;Journal of Affective Disorders. 2017 Oct 15
• 78 citations
  A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
  Atul R Mahableshwarkar, John Zajecka, William Jacobson, Yinzhong Chen, Richard Se Keefe> ;Neuropsychopharmacology. 2016 Nov 1
• 27 citations
  Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.
  Paula L. Jacobsen, Atul R. Mahableshwarkar, William Palo, Yinzhong Chen, Marianne Dragheim, Anita H. Clayton> ;CNS Spectrums. 2016 Oct 1
• 100 citations
  A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
  Michael E. Thase, Atul R. Mahableshwarkar, Marianne Dragheim, Henrik Loft, Eduard Vieta> ;European Neuropsychopharmacology. 2016 Jun 1
• 12 citations
  A Population Pharmacokinetic-Pharmacodynamic Meta-Analysis of Vortioxetine in Patients with Major Depressive Disorder.
  Himanshu Naik, Serena Chan, Majid Vakilynejad, Grace Chen, Henrik Loft, Atul R. Mahableshwarkar, Johan Areberg> ;Basic & Clinical Pharmacology & Toxicology. 2016 May 1
• 3 citations
  Association Between Cognitive Function and Health Care Costs 3 Months and 6 Months After Initiating Antidepressant Medication for Depressive Disorders
  Valery Walker, Haridarshan Patel, Jonathan Kurlander, Breanna Essoi, Jiao Yang, Atul R Mahableshwarkar, Jennifer C. Samp, Kasem S Akhras> ;Journal of Managed Care & Specialty Pharmacy. 2015 Oct 16
• 57 citations
  Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction
  Paula L. Jacobsen, Atul R. Mahableshwarkar, Yinzhong Chen, Lambros Chrones, Anita H. Clayton> ;The Journal of Sexual Medicine. 2015 Oct 1
• 85 citations
  A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.
  Paula L. Jacobsen, Atul R. Mahableshwarkar, Michael Serenko, Serena Chan, Madhukar H. Trivedi> ;The Journal of Clinical Psychiatry. 2015 May 1
• 63 citations
  A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder
  Atul R. Mahableshwarkar, Paula L. Jacobsen, Michael Serenko, Yinzhong Chen, Madhukar H. Trivedi> ;The Journal of Clinical Psychiatry. 2015 May 27
• 19 citations
  Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
  Paula L. Jacobsen, Linda Harper, Lambros Chrones, Serena Chan, Atul R. Mahableshwarkar> ;International Clinical Psychopharmacology. 2015 Sep 1
• 3 citations
  Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments.
  Steven T. Szabo, Bruce J. Kinon, Brannan Sk, Krystal Ak, van Gerven Jm, Atul R. Mahableshwarkar, Gary S. Sachs> ;Innovations in Clinical Neuroscience. 2015 Mar 1
• 129 citations
  A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
  Atul R Mahableshwarkar, John Zajecka, William Jacobson, Yinzhong Chen, Richard S E Keefe> ;Neuropsychopharmacology. 2015 Jul 1
• 67 citations
  A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.
  Atul R. Mahableshwarkar, Paula L. Jacobsen, Yinzhong Chen, Michael Serenko, Madhukar H. Trivedi> ;Psychopharmacology. 2015 Jan 11
• 30 citations
  A randomized, double‐blind, fixed‐dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiet...
  Atul R. Mahableshwarkar, Paula L. Jacobsen, Michael Serenko, Yinzhong Chen> ;Human Psychopharmacology. 2014 Jan 1
• 49 citations
  Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
  Mohammed Y. Alam, Paula L. Jacobsen, Yinzhong Chen, Michael Serenko, Atul R. Mahableshwarkar> ;International Clinical Psychopharmacology. 2014 Jan 1
• A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with gene...
  Mahableshwarkar, A. R.,Jacobsen, P. L.,Chen, Y.,Simon, J. S.> ;Int. J. Clin. Pract.. 2013 Dec 18
• 4 citations
  Study Site Experiences and Attitudes Toward Prospective Assessments of Suicidal Ideation and Behavior in Clinical Trials: Results of an Internet-based Survey.
  Michelle Stewart, Adam Butler, Larry Alphs, Phillip B. Chappell, Douglas Feltner, William R. Lenderking, Atul R. Mahableshwarkar, Clare Makumi, Sarah Dubrava> ;Innovations in Clinical Neuroscience. 2013 May 1
• 94 citations
  A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder
  Rakesh K. Jain, Atul R. Mahableshwarkar, Paula L. Jacobsen, Yinzhong Chen, Michael E. Thase> ;The International Journal of Neuropsychopharmacology. 2013 Mar 1
• 92 citations
  A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
  Atul R. Mahableshwarkar, Paula L. Jacobsen, Yinzhong Chen> ;Current Medical Research and Opinion. 2013 Jan 17
• 44 citations
  Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States
  Anthony J. Rothschild, Atul R. Mahableshwarkar, Paula L. Jacobsen, Mingjin Yan, David V. Sheehan> ;European Neuropsychopharmacology. 2012 Dec 1
• 113 citations
  A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.
  Neven Henigsberg, Atul R. Mahableshwarkar, Paula L. Jacobsen, Yinzhong Chen, Michael E. Thase> ;The Journal of Clinical Psychiatry. 2012 Jul 15
• Join now to see all

Lectures

• American Society for Experimental NeuroTherapeutics 14th Annual Meeting 
  American Society for Experimental NeuroTherapeutics(ASENT), Washington, Dist Of Col - 2/22/2012